Fundamentals

Valuation

Metric	Q2	Q3	Δ in %
EV/EBITDA	27.90	1561.48	-1220.82
Graham Fair Price	-13.27	4.56	5.26
PEG	-88.62	-2.02	17.72
Price/Book	-35.05	23.78	36.61
Price/Cash Flow	-39.39	211.09	348.29
Prices/Earnings	10.22	339.77	-308.26
Price/Sales	-29.73	46.98	66.86
Price/FCF	-39.39	211.09	348.29
Naive Interpretation	member

01 - Valuation · Bad

Fundamentals

Profitability

Metric	Q2	Q3	Δ in %
Gross Profit Margin	1.19	0.78	0.78
Operating Margin	91.08	< 0.005	-0.09
ROA	-37.06	< 0.005	< 0.005
ROE	-0.03	0.02	-41.08
ROIC	-0.03	< 0.005	94.17
Naive Interpretation	member

02 - Profitability · Not Interpreted

Fundamentals

Financial Growth

Metric	Q2	Q3	Δ in %
Debt QOQ	< 0.005	0.01	-90.37
Dividends QOQ	0.00	0.00	0.00
EBIT QOQ	-0.02	0.91	4027.50
EPS QOQ	0.17	1.68	868.42
FCF QOQ	-0.55	0.22	-59.81
Revenue QOQ	0.06	0.05	-5.70
Naive Interpretation	member

03 - Financial Growth · Balanced

Fundamentals

Leverage & Liquidity

Metric	Q2	Q3	Δ in %
Assets Turnover	n.A.	n.A.	n.A.
Days Inventory Outstanding (DIO)	0.00	0.00	0.00
Days Sales Outstanding (DSO)	83.93	84.09	0.19
Inventory Turnover	0.00	0.00	0.00
Debt/Capitalization	0.55	0.52	-5.79
Quick Ratio	1.86	1.62	-12.98
Naive Interpretation	member

04 - Leverage & Liquidity · Weak

Fundamentals

Per Share Metrics

Metric	Q2	Q3	Δ in %
Book Value	6.44	7.27	12.99
Cash	16.51	14.90	-9.75
Capex	-0.28	-0.33	-20.73
Free Cash Flow	0.68	0.82	21.07
Revenue	3.52	3.68	4.43
Naive Interpretation	member

05 - Per Share Metrics · Positive

Fundamentals

Financial Health

Metric	Q2	Q3	Δ in %
Current Ratio	1.90	1.67	-12.52
Debt/Assets	n.A.	n.A.	n.A.
Debt/Equity	n.A.	n.A.	n.A.
Net Debt/EBITDA	7.17	-1.43	-80.07
Naive Interpretation	Member

06 - Financial Health · Weak

Rating